LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | OSI-027 | 3.33 | uM | LJP6 | 72 | hr | 929 | 1500 | 3216 | 0.4665 | 0.3065 |
Hs 578T | OSI-027 | 10 | uM | LJP6 | 72 | hr | 929 | 1356 | 3216 | 0.4217 | 0.2344 |
Hs 578T | WYE-125132 | 0.12 | uM | LJP6 | 72 | hr | 929 | 1340 | 3216 | 0.4164 | 0.2259 |
Hs 578T | WYE-125132 | 0.37 | uM | LJP6 | 72 | hr | 929 | 1338 | 3216 | 0.4160 | 0.2252 |
Hs 578T | AT-7519 | 0.04 | uM | LJP6 | 72 | hr | 929 | 3200 | 3216 | 0.9948 | 0.9941 |
Hs 578T | AZD7762 | 0.37 | uM | LJP6 | 72 | hr | 929 | 1146 | 3216 | 0.3564 | 0.1243 |
Hs 578T | JW-7-24-1 | 1.11 | uM | LJP6 | 72 | hr | 929 | 2187 | 3216 | 0.6800 | 0.6126 |
Hs 578T | KIN001-043 | 0.12 | uM | LJP6 | 72 | hr | 929 | 3353 | 3216 | 1.0426 | 1.0472 |
Hs 578T | AT-7519 | 0.12 | uM | LJP6 | 72 | hr | 929 | 2782 | 3216 | 0.8649 | 0.8442 |
Hs 578T | AT-7519 | 0.37 | uM | LJP6 | 72 | hr | 929 | 967 | 3216 | 0.3006 | 0.0222 |
Hs 578T | AT-7519 | 3.33 | uM | LJP6 | 72 | hr | 929 | 737 | 3216 | 0.2291 | -0.1227 |
Hs 578T | AT-7519 | 10 | uM | LJP6 | 72 | hr | 929 | 616 | 3216 | 0.1917 | -0.2056 |
Hs 578T | AZD7762 | 1.11 | uM | LJP6 | 72 | hr | 929 | 1015 | 3216 | 0.3157 | 0.0506 |
Hs 578T | AZD7762 | 3.33 | uM | LJP6 | 72 | hr | 929 | 853 | 3216 | 0.2653 | -0.0466 |
Hs 578T | AZD8055 | 0.04 | uM | LJP6 | 72 | hr | 929 | 1457 | 3216 | 0.4532 | 0.2857 |
Hs 578T | AZD8055 | 0.12 | uM | LJP6 | 72 | hr | 929 | 1326 | 3216 | 0.4123 | 0.2195 |
Hs 578T | AZD8055 | 3.33 | uM | LJP6 | 72 | hr | 929 | 1264 | 3216 | 0.3929 | 0.1870 |
Hs 578T | AZD8055 | 10 | uM | LJP6 | 72 | hr | 929 | 1012 | 3216 | 0.3148 | 0.0486 |
Hs 578T | Sorafenib | 0.12 | uM | LJP6 | 72 | hr | 929 | 3812 | 3216 | 1.1852 | 1.1991 |
Hs 578T | Sorafenib | 0.37 | uM | LJP6 | 72 | hr | 929 | 3923 | 3216 | 1.2199 | 1.2347 |
Hs 578T | GW843682X | 0.04 | uM | LJP6 | 72 | hr | 929 | 3236 | 3216 | 1.0064 | 1.0071 |
Hs 578T | Palbociclib | 3.33 | uM | LJP6 | 72 | hr | 929 | 1645 | 3216 | 0.5114 | 0.3755 |
Hs 578T | PF562271 | 0.04 | uM | LJP6 | 72 | hr | 929 | 2878 | 3216 | 0.8949 | 0.8798 |
Hs 578T | Afatinib | 3.33 | uM | LJP6 | 72 | hr | 929 | 2740 | 3216 | 0.8516 | 0.8280 |
Hs 578T | Afatinib | 1.11 | uM | LJP6 | 72 | hr | 929 | 2985 | 3216 | 0.9281 | 0.9179 |